Association of age-related macular degeneration with erythrocyte antioxidant enzymes activity and serum total antioxidant status

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Plestina Borjan, Ivna ^a   Katusic, Damir ^b   Medvidovic Grubisic, Maria ^c   Supe Domic, Daniela ^a   Bucan, Kajo ^a   Tandara, Leida ^a   Rogosic, Veljko ^a  

^a UNIVERSITY OF SPLIT   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Institute of Navy Medicine   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BODY FLUIDS; ENZYMES; OPHTHALMOLOGY; OXYGEN;

AGE-RELATED MACULAR DEGENERATION; ANTIOXIDANT ENZYME; GLUTATHIONE PEROXIDASE; MATCHED CONTROLS; NEGATIVE PREDICTIVE VALUE; STANDARD DEVIATION; SUPEROXIDE DISMUTASES; TOTAL ANTIOXIDANT STATUS;

ANTIOXIDANTS;

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

AGE RELATED MACULAR DEGENERATION; AGED; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM; TOTAL ANTIOXIDANT STATUS; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; ERYTHROCYTE; MACULAR DEGENERATION; METABOLISM; MIDDLE AGED; ODDS RATIO; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; AREA UNDER CURVE; CASE-CONTROL STUDIES; CATALASE; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; ROC CURVE; SUPEROXIDE DISMUTASE;

EID: 84924533907     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/804054     Document Type: Article

References (82)

1. World Health Organization, "Vision 2020. The right to sight. Global initiative for the elimination of avoidable blindness. Magnitude and causes of visual impairment," Fact Sheet No. 282, 2004, http://whqlibdoc.who.int/fact-sheet/2004/FS-282.pdf.
2. World Health Organization, Vision 2020. The Right to Sight. Global Initiative for the Elimination of Avoidable Blindness. Actions Plan 2006-2011, World Health Organization, 2013, http://www.who.int/blindness/Vision2020-report.pdf
3. M. A. Zarbin, "Current concepts in the pathogenesis of age-related macular degeneration," Archives of Ophthalmology, vol. 122, no. 4, pp. 598-614, 2004.
4. H. R. Coleman, C.-C. Chan, F. L. Ferris III, and E. Y. Chew, "Age-related macular degeneration," The Lancet, vol. 372, no. 9652, pp. 1835-1845, 2008.
5. A. Lux, H. Llacer, F. M. A. Heussen, and A. M. Joussen, "Non-responders to bevacizumab (Avastin) therapy of choroidal neo-vascular lesions," British journal of Ophthalmology, vol. 91, no. 10, pp. 1318-1322, 2007.
6. X. Ding, M. Patel, and C.-C. Chan, "Molecular pathology of age-related macular degeneration," Progress in Retinal and Eye Research, vol. 28, no. 1, pp. 1-18, 2009.
7. M. A. Brantley Jr., M. P. Osborn, B. J. Sanders et al., "Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration," American journal of Ophthalmology, vol. 153, no. 3, pp. 460-467, 2012.
8. C. Delcourt, J.-R Cristol, C. L. Léger, B. Descomps, and L. Papoz, "Associations of antioxidant enzymes with cataract and age-related macular degeneration: the POLA study," Ophthalmology, vol. 106, no. 2, pp. 215-222, 1999.
9. S. Khandhadia, A. Crée, and A. Lotery, "Oxidative damage and macular degeneration," in Systems Biology of Free Radicals and Antioxidants, I. Lather, Ed., pp. 3625-3653, Springer, Berlin, Germany, 2014.
10. P. Tokarz, K. Kaarniranta, and J. Blasiak, "Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)," Biogerontology, vol. 14, no. 5, pp. 461-482, 2013.
11. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, New York, NY, USA, 3rd edition, 1999.
12. I. Pleština-Borjan and M. Klinger-Lasić, "Long-term exposure to solar ultraviolet radiation as a risk factor for age-related macular degeneration," Collegium Antropologicum, vol. 31, supplement 1, pp. 33-38, 2007
13. R. W. Young, "Solar radiation and age-related macular degeneration," Survey of Ophthalmology, vol. 32, no. 4, pp. 252-269, 1988.
14. G.-Y Sui, G.-C. Liu, G.-Y Liu et al., "Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis," British journal of Ophthalmology, vol. 97, no. 4, pp. 389-394, 2013.
15. D.-Y Yu and S. J. Cringle, "Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease," Progress in Retinal and Eye Research, vol. 20, no. 2, pp. 175-208, 2001.
16. P. N. Youssef, N. Sheibani, and D. M. Albert, "Retinal light toxicity," Eye, vol. 25, no. 1, pp. 1-14, 2011.
17. J. J. Hunter, J. I. W. Morgan, W. H. Merigan, D H. Sliney, J. R. Sparrow, and D. R. Williams, "The susceptibility of the retina to photochemical damage from visible light," Progress in Retinal and Eye Research, vol. 31, no. 1, pp. 28-42, 2012.
18. J. R. Sparrow, E. Gregory-Roberts, K. Yamamoto et al., "The bisretinoids of retinal pigment epithelium," Progress in Retinal and Eye Research, vol. 31, no. 2, pp. 121-135, 2012.
19. J. Curran-Celentano, J. Hammond B.R., T. A. Ciulla, D. A. Cooper, L. M. Pratt, and R. B. Danis, "Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population," American journal of Clinical Nutrition, vol. 74, no. 6, pp. 796-802, 2001.
20. R. N. Frank, R. H. Amin, and J. E. Puklin, "Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration," The American journal of Ophthalmology, vol. 127, no. 6, pp. 694-709, 1999.
21. E. Kaemmerer, F. Schutt, T. U. Krohne, F. G. Holz, and J. Kopitz, "Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis," Investigative Ophthalmology and Visual Science, vol. 48, no. 3, pp. 1342-1347, 2007
22. M. G. Nicolas, K. Fujiki, K. Murayama et al., "Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress," Experimental Eye Research, vol. 62, no. 4, pp. 399-408, 1996.
23. A. E. Fletcher, "Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration," Ophthalmic Research, vol. 44, no. 3, pp. 191-198, 2010.
24. World Medical Association Declaration of Helsinki, "Ethical principles for medical research involving human subjects," Bulletin of the World Health Organization, vol. 79, no. 4, pp. 373-374, 2001.
25. A. C. Bird, N. M. Bressler, S. B. Bressler et al., "An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group," Survey of Ophthalmology, vol. 39, no. 5, pp. 367-374, 1995.
26. C. G Winterbourn, R. E. Hawkins, M. Brian, and R. W. Carrell, "The estimation of red cell superoxide dismutase activity," journal of Laboratory and Clinical Medicine, vol. 85, no. 2, pp. 337-341, 1975.
27. D. E. Paglia and W. N. Valentine, "Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase," The journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158-169, 1967
28. N. J. Miller, G Rice-Evans, M. J. Davies, V. Gopinathan, and A. Milner, "A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates," Clinical Science, vol. 84, no. 4, pp. 407-412, 1993.
29. D. G. Bonett and R. M. Price, "Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements," Psychological Methods, vol. 7, no. 3, pp. 370-383, 2002.
30. M. R. Liles, D. A. Newsome, and P. D. Oliver, "Antioxidant enzymes in the aging human retinal pigment epithelium," Archives of Ophthalmology, vol. 109, no. 9, pp. 1285-1288, 1991.
31. Z. Liu, L. Sun, L. Zhu et al., "Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction," journal of Neurochemistry, vol. 103, no. 6, pp. 2690-2700, 2007
32. V. Justitien, J.-J. Pang, K. Renganathan et al., "SOD2 knockdown mouse model of early AMD," Investigative Ophthalmology and Visual Science, vol. 48, no. 10, pp. 4407-4420, 2007
33. Z. Yildirim, N. I. Ucgun, and F. Yildirim, "The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration," Clinics, vol. 66, no. 5, pp. 743-746, 2011.
34. A. Anand, N. K. Sharma, A. Gupta, S. Prabhakar, S. K. Sharma, and R. Singh, "Superoxide dismutasel levels in north Indian population with age-related macular degeneration," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 365046, 7 pages, 2013.
35. X. L. Shen, L. H. Jia, P. Zhao et al., "Changes in blood oxidative and antioxidant parameters in a group of chinese patients with age-related macular degeneration," Journal of Nutrition, Health and Aging, vol. 16, no. 3, pp. 201-204, 2012.
36. H. Lin, H. Xu, F.-Q. Liang et al., "Mitochondrial DNA damage and repair in rpe associated with aging and age-related macular degeneration," Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 3521-3529, 2011.
37. S. M. Cohen, K. L. Olin, W. J. Feuer, L. Hjelmeland, C. L. Keen, and L. S. Morse, "Low glutathione reductase and peroxidase activity in age-related macular degeneration," British journal of Ophthalmology, vol. 78, no. 10, pp. 791-794, 1994.
38. L. Lu, B. C. Oveson, Y.-J. Jo et al., "Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage," Antioxidants and Redox Signaling, vol. 11, no. 4, pp. 715-724, 2009.
39. 2-detoxifying enzyme in same cellular compartment," Free Radical Biology and Medicine, vol. 51, no. 7, pp. 1347-1354, 2011.
40. Y. Totan, R. Yagci, Y Bardak et al., "Oxidative macromolecular damage in age-related macular degeneration," Current Eye Research, vol. 34, no. 12, pp. 1089-1093, 2009.
41. J. Lamont, J. Campbell, and P. FitzGerald, "Measurement of individual vs total antioxidants," Clinical Chemistry, vol. 43, no. 5, pp. 852-854, 1997
42. World Health Organization, "Vision 2020. The right to sight. Global initiative for the elimination of avoidable blindness. Magnitude and causes of visual impairment," Fact Sheet No. 282, 2004, http://whqlibdoc.who.int/fact-sheet/2004/FS-282.pdf.
43. World Health Organization, Vision 2020. The Right to Sight. Global Initiative for the Elimination of Avoidable Blindness. Actions Plan 2006-2011, World Health Organization, 2013, http://www.who.int/blindness/Vision2020-report.pdf
44. M. A. Zarbin, "Current concepts in the pathogenesis of age-related macular degeneration," Archives of Ophthalmology, vol. 122, no. 4, pp. 598-614, 2004.
45. H. R. Coleman, C.-C. Chan, F. L. Ferris III, and E. Y. Chew, "Age-related macular degeneration," The Lancet, vol. 372, no. 9652, pp. 1835-1845, 2008.
46. A. Lux, H. Llacer, F. M. A. Heussen, and A. M. Joussen, "Non-responders to bevacizumab (Avastin) therapy of choroidal neo-vascular lesions," British journal of Ophthalmology, vol. 91, no. 10, pp. 1318-1322, 2007.
47. X. Ding, M. Patel, and C.-C. Chan, "Molecular pathology of age-related macular degeneration," Progress in Retinal and Eye Research, vol. 28, no. 1, pp. 1-18, 2009.
48. M. A. Brantley Jr., M. P. Osborn, B. J. Sanders et al., "Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration," American journal of Ophthalmology, vol. 153, no. 3, pp. 460-467, 2012.
49. C. Delcourt, J.-R Cristol, C. L. Léger, B. Descomps, and L. Papoz, "Associations of antioxidant enzymes with cataract and age-related macular degeneration: the POLA study," Ophthalmology, vol. 106, no. 2, pp. 215-222, 1999.
50. S. Khandhadia, A. Crée, and A. Lotery, "Oxidative damage and macular degeneration," in Systems Biology of Free Radicals and Antioxidants, I. Lather, Ed., pp. 3625-3653, Springer, Berlin, Germany, 2014.
51. P. Tokarz, K. Kaarniranta, and J. Blasiak, "Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)," Biogerontology, vol. 14, no. 5, pp. 461-482, 2013.
52. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, New York, NY, USA, 3rd edition, 1999.
53. I. Pleština-Borjan and M. Klinger-Lasić, "Long-term exposure to solar ultraviolet radiation as a risk factor for age-related macular degeneration," Collegium Antropologicum, vol. 31, supplement 1, pp. 33-38, 2007
54. R. W. Young, "Solar radiation and age-related macular degeneration," Survey of Ophthalmology, vol. 32, no. 4, pp. 252-269, 1988.
55. G.-Y Sui, G.-C. Liu, G.-Y Liu et al., "Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis," British journal of Ophthalmology, vol. 97, no. 4, pp. 389-394, 2013.
56. D.-Y Yu and S. J. Cringle, "Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease," Progress in Retinal and Eye Research, vol. 20, no. 2, pp. 175-208, 2001.
57. P. N. Youssef, N. Sheibani, and D. M. Albert, "Retinal light toxicity," Eye, vol. 25, no. 1, pp. 1-14, 2011.
58. J. J. Hunter, J. I. W. Morgan, W. H. Merigan, D H. Sliney, J. R. Sparrow, and D. R. Williams, "The susceptibility of the retina to photochemical damage from visible light," Progress in Retinal and Eye Research, vol. 31, no. 1, pp. 28-42, 2012.
59. J. R. Sparrow, E. Gregory-Roberts, K. Yamamoto et al., "The bisretinoids of retinal pigment epithelium," Progress in Retinal and Eye Research, vol. 31, no. 2, pp. 121-135, 2012.
60. J. Curran-Celentano, J. Hammond B.R., T. A. Ciulla, D. A. Cooper, L. M. Pratt, and R. B. Danis, "Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population," American journal of Clinical Nutrition, vol. 74, no. 6, pp. 796-802, 2001.
61. R. N. Frank, R. H. Amin, and J. E. Puklin, "Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration," The American journal of Ophthalmology, vol. 127, no. 6, pp. 694-709, 1999.
62. E. Kaemmerer, F. Schutt, T. U. Krohne, F. G. Holz, and J. Kopitz, "Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis," Investigative Ophthalmology and Visual Science, vol. 48, no. 3, pp. 1342-1347, 2007
63. M. G. Nicolas, K. Fujiki, K. Murayama et al., "Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress," Experimental Eye Research, vol. 62, no. 4, pp. 399-408, 1996.
64. A. E. Fletcher, "Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration," Ophthalmic Research, vol. 44, no. 3, pp. 191-198, 2010.
65. World Medical Association Declaration of Helsinki, "Ethical principles for medical research involving human subjects," Bulletin of the World Health Organization, vol. 79, no. 4, pp. 373-374, 2001.
66. A. C. Bird, N. M. Bressler, S. B. Bressler et al., "An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group," Survey of Ophthalmology, vol. 39, no. 5, pp. 367-374, 1995.
67. C. G Winterbourn, R. E. Hawkins, M. Brian, and R. W. Carrell, "The estimation of red cell superoxide dismutase activity," journal of Laboratory and Clinical Medicine, vol. 85, no. 2, pp. 337-341, 1975.
68. D. E. Paglia and W. N. Valentine, "Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase," The journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158-169, 1967
69. N. J. Miller, G Rice-Evans, M. J. Davies, V. Gopinathan, and A. Milner, "A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates," Clinical Science, vol. 84, no. 4, pp. 407-412, 1993.
70. D. G. Bonett and R. M. Price, "Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements," Psychological Methods, vol. 7, no. 3, pp. 370-383, 2002.
71. M. R. Liles, D. A. Newsome, and P. D. Oliver, "Antioxidant enzymes in the aging human retinal pigment epithelium," Archives of Ophthalmology, vol. 109, no. 9, pp. 1285-1288, 1991.
72. Z. Liu, L. Sun, L. Zhu et al., "Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction," journal of Neurochemistry, vol. 103, no. 6, pp. 2690-2700, 2007
73. V. Justitien, J.-J. Pang, K. Renganathan et al., "SOD2 knockdown mouse model of early AMD," Investigative Ophthalmology and Visual Science, vol. 48, no. 10, pp. 4407-4420, 2007
74. Z. Yildirim, N. I. Ucgun, and F. Yildirim, "The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration," Clinics, vol. 66, no. 5, pp. 743-746, 2011.
75. A. Anand, N. K. Sharma, A. Gupta, S. Prabhakar, S. K. Sharma, and R. Singh, "Superoxide dismutasel levels in north Indian population with age-related macular degeneration," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 365046, 7 pages, 2013.
76. X. L. Shen, L. H. Jia, P. Zhao et al., "Changes in blood oxidative and antioxidant parameters in a group of chinese patients with age-related macular degeneration," Journal of Nutrition, Health and Aging, vol. 16, no. 3, pp. 201-204, 2012.
77. H. Lin, H. Xu, F.-Q. Liang et al., "Mitochondrial DNA damage and repair in rpe associated with aging and age-related macular degeneration," Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 3521-3529, 2011.
78. S. M. Cohen, K. L. Olin, W. J. Feuer, L. Hjelmeland, C. L. Keen, and L. S. Morse, "Low glutathione reductase and peroxidase activity in age-related macular degeneration," British journal of Ophthalmology, vol. 78, no. 10, pp. 791-794, 1994.
79. L. Lu, B. C. Oveson, Y.-J. Jo et al., "Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage," Antioxidants and Redox Signaling, vol. 11, no. 4, pp. 715-724, 2009.
80. 2-detoxifying enzyme in same cellular compartment," Free Radical Biology and Medicine, vol. 51, no. 7, pp. 1347-1354, 2011.
81. Y. Totan, R. Yagci, Y Bardak et al., "Oxidative macromolecular damage in age-related macular degeneration," Current Eye Research, vol. 34, no. 12, pp. 1089-1093, 2009.
82. J. Lamont, J. Campbell, and P. FitzGerald, "Measurement of individual vs total antioxidants," Clinical Chemistry, vol. 43, no. 5, pp. 852-854, 1997